Participating Staff Sample Clauses

Participating Staff. The Institution shall choose the Investigator on its own responsibility. The Institution hereby declares that the Investigator has undergone the necessary training and has the required experience and means for conducting the Trial. The Institution shall guarantee that this Agreement will be duly performed by the Investigator chosen on its responsibility. The Institution shall not be able to replace the Investigator with another Investigator without the prior written consent of Biogen. The Institution shall provide, and shall cause the Investigator to provide, Biogen and its representatives with information regarding the staff participating in the Trial (the Staff). For the avoidance of doubt, the Staff shall throughout the term of this Agreement be under the supervision and control of the Institution and the Investigator, and the Institution and Investigator shall without limitation be responsible for ensuring that the Staff act in accordance with the Applicable Laws and Regulations and, Biogen’s and its representatives’ reasonable instructions. Zdravotnické zařízení pověří příslušně kvalifikovaného zaměstnance a člena Personálu v pozici farmaceuta k zajištění řádného zacházení a následného výdeje Produktu dle požadavků Zkoušejícího, v souladu se Správnou lékárenskou praxí (vyhláška č. 84/2008 Sb.), Platnými zákony a předpisy a ustanoveními Protokolu. The Institution will authorize an employee and member of the Staff appropriately qualified to act as the pharmacist to secure proper handling and subsequent distribution of the Product as requested by the Investigator, and in accordance with Good Pharmacy Practice (Regulation No. 84/2008 Coll.), Applicable Laws and Regulations and the provisions of the Protocol.
AutoNDA by SimpleDocs
Participating Staff. The Investigator hereby declares that he/she has undergone the necessary training and has the required experience and means for conducting the Trial. The Institution acknowledges that Investigator shall guarantee that this Agreement will be duly performed. The Institution shall not be able to replace the Investigator with another Investigator without the prior written consent of Biogen. The Institution shall provide, and shall cause the Investigator to provide, Biogen and its representatives with information regarding the staff participating in the Trial (the Staff). For the avoidance of doubt, the Staff shall throughout the term of this Agreement be under the supervision and control of the Institution and the Investigator, and the Institution and Investigator shall without limitation be responsible for ensuring that the Staff act in accordance with the Applicable Laws and Regulations and, Biogen’s and its representatives’ reasonable instructions. (b) Xxxxxxxxxx xxxxxxxx. Xxxxxxxxxx xxxxx xxxxxxxxxx, xx Zkoušející prošel nezbytným školením a má požadované zkušenosti a prostředky pro provádění Klinického hodnocení. Zdravotnické zařízení bere na vědomí, že Zkoušející je povinen se zaručit, že bude tuto smlouvu řádně plnit. Zdravotnické zařízení nesmí Zkoušejícího nahradit jiným Zkoušejícím bez předchozího písemného souhlasu společnosti Biogen. Zdravotnické zařízení bude společnosti Biogen a jejím zástupcům poskytovat (a zajistí, aby tak činil i Zkoušející) informace ohledně pracovníků podílejících se na Klinickém hodnocení (dále jen „Personál“). Aby se předešlo jakýmkoliv pochybnostem, bude Personál po dobu trvání této smlouvy pod dozorem a kontrolou Zdravotnického zařízení a Zkoušejícího a Zdravotnické zařízení a Zkoušející ponesou neomezenou odpovědnost za to, že Personál bude jednat v souladu s příslušnými zákony a právními předpisy a podle pokynů společnosti Biogen či jejích zástupců. The Institution will authorize an employee and member of the Staff appropriately qualified to act as the pharmacist to secure proper handling and subsequent distribution of the Product as requested by the Investigator, and in accordance with Good Pharmacy Practice (Regulation No. 84/2008 Coll.), Applicable Laws and Regulations and the provisions of the Protocol. Zdravotnické zařízení pověří příslušně kvalifikovaného zaměstnance a člena Personálu v pozici farmaceuta k zajištění řádného zacházení a následného výdeje Produktu dle požadavků Zkoušejícího, v souladu se Správnou l...
Participating Staff. Biogen shall appoint the Investigator as the medical specialist responsible for the conduct of the Trial on its own responsibility. The Institution hereby declares that the Investigator has undergone the necessary training and has the required experience, skills, knowledge and facilities for conducting the Trial. The Institution shall guarantee that the Trial will be duly performed by the Investigator in accordance with this Agreement. The Institution shall not be able to replace the Investigator with another investigator without the prior written consent of Biogen. The Investigator shall provide Biogen and its representatives with information regarding the other staff participating in the Trial (the Investigator and the other staff collectively referred to as the “Staff”). For the avoidance of doubt, the Staff shall throughout the term of this Agreement be under the supervision and control of the Institution. The Institution acknowledges and agrees that the Investigator enters into a separate agreement with Biogen and the CRO under which he/she will receive direct payment from the CRO for the services performed by the Investigator in connection with the Trial and by the other Staff members. The Institution assures that the performance of this separate agreement between Biogen and the Investigator will not constitute a violation of the Investigator’s duties nor a violation of the other Staff members’ duties. Agreements shall be concluded between Biogen and each respective Staff member, including but not limited to the Investigator, which shall stipulate terms and conditions of remuneration for each Staff member. Members of the Staff shall be solely responsible for due taxation of their income. Zdravotnické zařízení pověří příslušně kvalifikovaného zaměstnance a člena Personálu v pozici farmaceuta k zajištění řádného zacházení a následného výdeje Produktu dle požadavků Zkoušejícího, v souladu se Správnou lékárenskou praxí (vyhláška č. 84/2008 Sb.), Platnými zákony The Institution will authorize an employee and member of the Staff appropriately qualified to act as the pharmacist to secure proper handling and subsequent distribution of the Product as requested by the Investigator, and in accordance with Good Pharmacy Practice (Regulation No. 84/2008 Coll.), Applicable Laws and Regulations and the provisions a předpisy a ustanoveními Protokolu. of the Protocol.
Participating Staff. The InstitutionFoundation shall choose the Investigator on its own responsibility. The InstitutionFoundation hereby declares that the Investigator has undergone the necessary training and has the required experience and means for conducting the Trial. The InstitutionFoundation shall guarantee that this Agreement will be duly performed by the Investigator chosen on its responsibility. The InstitutionFoundation shall not be able to replace the Investigator with another Investigator without the prior written consent of Biogen. The InstitutionFoundation shall provide, and shall cause the Investigator to provide, Biogen and its representatives with information regarding the staff participating in the Trial (the Staff). For the avoidance of doubt the Staff shall throughout the term of this Agreement be under the supervision and control of the InstitutionFoundation and the Investigator, and the InstitutionFoundation and Investigator shall without limitation be responsible for ensuring that the Staff act in accordance with the Applicable Laws and Regulations and, Biogen’s and its representatives’ reasonable instructions. (b)
Participating Staff. The Investigator declares to have undergone the necessary training and has the required experience and means for conducting the Trial. The Institution shall supervise that the Trial will be duly performed by the Investigator in accordance with this Agreement. The Institution shall not be able to replace the Investigator with another investigator without the prior written consent of Biogen. The Investigator shall provideBiogen and its representatives with information regarding the other staff participating in the Trial (the Investigator and the other staff collectively referred to as the “Staff”). For the avoidance of doubt, the Staff shall throughout the term of this Agreement be under the supervision and control of the Institution, and the Institution shall be responsible for ensuring that the Staff act in accordance with the Applicable Laws and Regulations and, Biogen’s and its representatives’ reasonable instructions. The Institution acknowledges and agrees that the Investigator enters into a separate agreement with Biogen and the CRO under which he/she will receive direct payment from the CRO for the services performed by the Investigator in connection with the Trial and by the other Staff members. The Investigator shall be responsible for the compensation of any Staff members that he/she decides to use in connection with the conduct of the Trial. The Institution assures that the performance of this separate agreement between Biogen and the Investigator will not constitute a violation of the Investigator’s duties nor a violation of the other Staff members’ duties toward Institution.

Related to Participating Staff

  • Participating Teachers A participating Teacher is a unit member who receives assistance and/or coaching to improve instructional skills, classroom management, knowledge of subject, and related aspects of teaching performance. There are two (2) categories of Participating Teachers.

  • Participating Consumers All Participating Consumers as of the Effective Date will continue to be enrolled in the Program under the terms of this ESA unless they opt-out. Within one (1) day after the Effective Date, the Town shall provide to Competitive Supplier a list of Participating Consumers as of the Effective Date, as well as such Participating Consumers’ service and billing addresses, and any other information necessary for Competitive Supplier to commence All-Requirements Power Supply to such Participating Consumers as of the Service Commencement Date.

  • All Employees to be Members ‌ All employees of the Employer, as a condition of continuing employment, shall become and remain members in good standing of the Union, according to the Constitution and By-Laws of the Union. All future employees of the Employer shall, as a condition of continued employment, become and remain members in good standing in the Union from the date of hire.

  • Participating Employers (a) With the consent of the Employer and Trustee, and by duly authorized action, any Affiliated Employer may adopt this Plan and become a Participating Employer.

  • Executive Management The PH-MCO must include in its Executive Management structure: • A full-time Administrator with authority over the entire operation of the PH-MCO. • A full-time HealthChoices Program Manager to oversee the operation of the Agreement, if different than the Administrator. • A full-time Medical Director who is a current Pennsylvania-licensed physician. The Medical Director must be actively involved in all major clinical program components of the PH-MCO and directly participates in the oversight of the SNU, QM Department and UM Department. The Medical Director and his/her staff/consultant physicians must devote sufficient time to the PH-MCO to provide timely medical decisions, including after-hours consultation, as needed. • A full-time Pharmacy Director who is a current Pennsylvania-licensed pharmacist. The Pharmacy Director oversees the outpatient drug management and serves on the PH-MCO P&T Committee. • A Dental Director who is a current Pennsylvania-licensed Doctor of Dental Medicine or Doctor of Dental Surgery. The Dental Director may be a consultant or employee but must be available at a minimum of 30 hours per week. The Dental Director must be actively involved in all program components related to dental services including, but not limited to, dental provider recruitment strategy, assessment of dental network adequacy, providing oversight and strategic direction in the quality of dental services provided, actively engaged in the development and implementation of quality initiatives, and monitor the performance of the dental benefit manger if dental benefits are subcontracted. A full-time Director of Quality Management who is a Pennsylvania- licensed RN, physician or physician's assistant or is a Certified Professional in Healthcare Quality by the National Association for Healthcare Quality Certified in Healthcare Quality and Management by the American Board of Quality Assurance and Utilization Review Providers. The Director of Quality Management must be located in Pennsylvania and have experience in quality management and quality improvement. Sufficient local staffing under this position must be in place to meet QM Requirements. The primary functions of the Director of Quality Management position are: • Evaluate individual and systemic quality of care • Integrate quality throughout the organization • Implement process improvement • Resolve, track, and trend quality of care complaints • Develop and maintain a credentialed Provider network • A full-time CFO to oversee the budget and accounting systems implemented by the PH-MCO. The CFO must ensure the timeliness and accuracy of all financial reports. The CFO shall devote sufficient time and resources to responsibilities under this Agreement. • A full-time Information Systems Coordinator, who is responsible for the oversight of all information systems issues with the Department. The Information Systems Coordinator must have a good working knowledge of the PH-MCO's entire program and operation, as well as the technical expertise to answer questions related to the operation of the information system. • These full time positions must be solely dedicated to the PA HealthChoices Program.

  • Participating Providers To find out if a Provider is a Participating Provider: • Check Our Provider directory, available at Your request; • Call the number on Your ID card; or • Visit our website at xxx.xxxxxx.xxx. The Provider directory will give You the following information about Our Participating Providers: • Name, address, and telephone number; • Specialty; • Board certification (if applicable); • Languages spoken; and • Whether the Participating Provider is accepting new patients.

  • Eligible Employees Regular and probationary, full time and less than full-time employees (on a pro rata basis) are eligible to participate in this program. Sec. 903 COURSES ELIGIBLE: The following criteria will be used in determining eligibility for reimbursement:

  • Benefits Committee As per LOA#10, a benefits committee comprised of the employee representatives and the employer representatives, including the Crown, shall convene upon request to address all matters that may arise in the operation of the OSSTF ELHT.

  • Senior Management If a Dispute occurs that the senior representatives of the Parties responsible for the transaction contemplated by this Agreement have been unable to settle or agree upon within a period of fifteen (15) days after such Dispute arose, Sellers shall nominate and commit one of Panther’s senior officers, and Buyer shall nominate and commit one of its senior officers, to meet at a mutually agreed time and place not later than thirty (30) days after the Dispute arose to attempt to resolve same. If such senior management have been unable to resolve such Dispute within a period of fifteen (15) days after such meeting, or if such meeting has not occurred within forty-five (45) days after such Dispute arose, then any Party shall have the right, by written notice to the other, to resolve the Dispute through the relevant Independent Expert pursuant to Section 16.03.

  • Agreement not to Participate in Company’s Competitors During Executive’s employment with the Company, Executive agrees not to acquire, assume or participate in, directly or indirectly, any position, investment or interest known by Executive to be adverse or antagonistic to the Company, its business, or prospects, financial or otherwise, or in any company, person, or entity that is, directly or indirectly, in competition with the business of the Company or any of its Affiliates (as defined below). Ownership by Executive, in professionally managed funds over which the Executive does not have control or discretion in investment decisions, or as a passive investment, of less than two percent (2%) of the outstanding shares of capital stock of any corporation with one or more classes of its capital stock listed on a national securities exchange or publicly traded on a national securities exchange or in the over-the-counter market shall not constitute a breach of this Section. For purposes of this Agreement, “Affiliate,” means, with respect to any specific entity, any other entity that, directly or indirectly, through one or more intermediaries, controls, is controlled by or is under common control with such specified entity.

Time is Money Join Law Insider Premium to draft better contracts faster.